Tempus AI Sees 2026 Adjusted EBITDA of About $65M

BioMar Group Raises 2026 Revenue and EBIT Guidance, Lowers Volume Outlook M impact | EARNINGS | Nov 02, 2026, 02:54 PM UTC

BioMar Updates FY2026 EBIT Guidance to DKK 1,290–1,360 Million M impact | EARNINGS | Nov 02, 2026, 02:46 PM UTC

US Stocks Rise to Kick Off November US stocks rose at the start of November, with the S&P 500 up 0.5%, the Nasdaq gaining 0.7% and the Dow Jones advancing nearly 400 points, following Friday’s sell-off in AI-related H impact | EARNINGS | Nov 02, 2026, 02:41 PM UTC

BioMar Updates FY2026 Revenue Guidance to DKK 17.8–18.6 Billion M impact | EARNINGS | Nov 02, 2026, 02:41 PM UTC

BioMar changes full-year 2026 expectations BioMar has announced a change to its full-year 2026 expectations. M impact | EARNINGS | Nov 02, 2026, 02:41 PM UTC

Tempus AI shares rise 6.2% after Q3 profit M impact | EQUITY | Nov 02, 2026, 02:40 PM UTC

Tempus AI Sees 2026 Adjusted EBITDA of About $65M

Related stories